Designing a Leadership Response to a Safety Event
A patient on a telemetry unit received a tenfold overdose of a high-alert medication because two vials with similar labels were stocked side by side in the automated dispensing cabinet. The patient required transfer to the ICU and recovered. The event was reported through the safety system. The nurse involved, a two-year employee with a clean record, is distraught and has asked whether she will be fired. The unit manager wants to 'make an example' to reinforce vigilance. The pharmacy has known about the look-alike labels for months but had not changed them. The hospital is preparing for a Joint Commission survey and the risk manager is concerned about discoverability of the event report.
1. How would you advise the unit manager on the response to the nurse, and why?
Read the worked answer
I would advise against 'making an example' and explain the just-culture framework.
- The error was a system-induced slip: look-alike labels stocked adjacently is a latent hazard the organization knew about. The nurse's conduct was not reckless; she reported the event and has a clean record. A system error should not be met with individual punishment.
- 'Making an example' would suppress future reporting, which is the opposite of what a safety program needs. The most valuable asset after an error is honest reporting.
- The appropriate response is support and disclosure: ensure the nurse has EAP support, is included in the improvement work, and receives a fair, consistent process. If there were genuine reckless behavior (e.g., bypassing a safety check knowingly), that would be handled separately under a defined policy.
I would tell the manager: your job is to fix the cabinet and the labels, and to make sure this nurse trusts the reporting system enough to report the next near-miss.
2. What system fixes would you prioritize, and how would you sequence them?
Read the worked answer
I would use a hierarchy-of-controls approach, strongest first.
- Eliminate the hazard: remove one of the look-alike products or switch to a single concentration/formulary where clinically acceptable. This is the most durable fix.
- Engineer the system: separate storage locations in the ADC, use tall-man lettering and distinct colors, add hard stops or alerts for high-alert medications, and consider barcode scanning at administration if not already in place.
- Administrative controls: independent double-check for high-alert meds, staff education on the specific look-alikes.
- Monitor: track near-misses and errors for these products and audit double-check compliance.
Sequencing: physical separation and labeling first (fast, high-yield), then formulary review with pharmacy and clinical leadership, then education and audit. I would assign owners and dates and report progress to the safety committee.
3. The risk manager raises discoverability concerns about the event report. How do you balance safety learning with legal protection?
Read the worked answer
I would separate the patient disclosure from the internal learning record.
- Disclose to the patient promptly and honestly - this is an ethical and often regulatory obligation, and disclosure is not the same as the internal analysis.
- Protect the learning record where the law allows: route the event through the patient-safety evaluation system and, where applicable, the peer-review or quality-improvement process, with counsel advising on privilege and state law. Do not assume privilege; verify it.
- Keep the factual medical record factual: document what happened and the clinical response, not speculation or blame.
- Do not let legal concerns freeze improvement: the system fix proceeds regardless of the report's discoverability.
I would coordinate with risk management and counsel so the disclosure, the record, and the safety analysis are each handled correctly.